Literature DB >> 23749586

Pharmacokinetic interaction of enrofloxacin/trimethoprim combination following single-dose intraperitoneal and oral administration in rats.

Myung-Jin Choi1, Sileshi Belew Yohannes, Seung-Jin Lee, Dereje Damte, Jong-Choon Kim, Joo-Won Suh, Seung-Chun Park.   

Abstract

The pharmacokinetic interaction of enrofloxacin and trimethoprim was evaluated after single-dose intraperitoneal or oral co-administration in rats. Plasma concentrations of the two drugs were determined by high-performance liquid chromatography. Following intraperitoneal combination, a significant (P < 0.05) increase in mean values of plasma half-life (t 1/2) and maximum plasma concentration (C max) was observed for enrofloxacin and trimethoprim, respectively. There was a significant (P < 0.05) increase in mean values of area under the plasma drug concentration versus time from time zero to infinity (AUC0-∞) and C max between combined oral doses (10, 30 and 100 mg/kg) of both antibacterial drugs. Also, after oral conjugation a significant difference in mean values of MRT0-∞ was observed between lower (10 mg/kg) and higher (100 mg/kg) doses of both drugs. A significant increase in pharmacokinetic parameters of both drugs in combined intraperitoneal and oral doses indicated pharmacokinetic interaction of enrofloxacin and trimethoprim. Further study is recommended in other species of animals.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23749586     DOI: 10.1007/s13318-013-0142-0

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  26 in total

1.  Mechanism of the antimicrobial drug trimethoprim revisited.

Authors:  E P Quinlivan; J McPartlin; D G Weir; J Scott
Journal:  FASEB J       Date:  2000-12       Impact factor: 5.191

2.  Pharmacokinetics of enrofloxacin and the rate of formation of its metabolite ciprofloxacin following intravenous and intramuscular single dose administration to male buffalo calves.

Authors:  P K Sharma; A H Ahmad; L D Sharma; Rachna Varma
Journal:  Vet J       Date:  2003-07       Impact factor: 2.688

3.  Pharmacokinetic interactions of flunixin meglumine and enrofloxacin in ICR mice.

Authors:  Tomoe Ogino; Toshiro Arai
Journal:  Exp Anim       Date:  2007-04

Review 4.  Mechanisms of action of antimicrobials: focus on fluoroquinolones.

Authors:  D C Hooper
Journal:  Clin Infect Dis       Date:  2001-03-15       Impact factor: 9.079

5.  Studies on sulfamethoxazole-trimethoprim. Absorption, distribution, excretion and metabolism of trimethoprim in rat.

Authors:  T Meshi; Y Sato
Journal:  Chem Pharm Bull (Tokyo)       Date:  1972-10       Impact factor: 1.645

Review 6.  Synergism and antagonism.

Authors:  G M Eliopoulos
Journal:  Infect Dis Clin North Am       Date:  1989-09       Impact factor: 5.982

7.  Dose-dependent increase of saquinavir bioavailability by the pharmaceutic aid cremophor EL.

Authors:  Meret Martin-Facklam; Jürgen Burhenne; Reinhard Ding; Ruth Fricker; Gerd Mikus; Ingeborg Walter-Sack; Walter E Haefeli
Journal:  Br J Clin Pharmacol       Date:  2002-06       Impact factor: 4.335

8.  The effect of endotoxin and dexamethasone on enrofloxacin pharmacokinetic parameters in swine.

Authors:  Lynn O Post; Dorothy E Farrell; Carol V Cope; John D Baker; Michael J Myers
Journal:  J Pharmacol Exp Ther       Date:  2003-02       Impact factor: 4.030

9.  Effect of probenecid on kinetics of enrofloxacin in lactating goats after subcutaneous administration.

Authors:  Jai Prakash Narayan; Nirbhay Kumar; H N Jha; C Jayachandran
Journal:  Indian J Exp Biol       Date:  2009-01       Impact factor: 0.818

10.  Pharmacokinetics after intravenous and oral administration of enrofloxacin in sheep.

Authors:  Eden C Bermingham; Mark G Papich
Journal:  Am J Vet Res       Date:  2002-07       Impact factor: 1.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.